My latest column for Forbes.com: The Apothecary, explaining why throwing more money at the Food and Drug Administration will not improve the productivity of regulation of medical devices. Read it here.
skip to main |
skip to sidebar
You can replace this text by going to "Layout" and then "Page Elements" section. Edit " About "
-
Categories
- 10th Amendment (1)
- Benjamin Rush Society (3)
- California (1)
- Canada (1)
- Connectors/Exchanges (1)
- consumer-driven health care (2)
- FDA (4)
- Forbes Apothecary (4)
- Health Policy Prescriptions (5)
- Health Savings Accounts (1)
- individual mandate (3)
- innovation (4)
- insurance regulation (2)
- Massachusetts (1)
- Medicaid (1)
- Obamacare (14)
- pharmaceuticals (3)
- Sebelius (1)
- Switzerland (1)
- tax reform (1)
0 komentar:
Posting Komentar